Swiss AI drug trial startup receives funding from Spotify-backer Creandum

Economic Times Techen

Swiss AI drug trial startup receives funding from Spotify-backer Creandum

An AI foundation model, trained on about two million human RNA readouts, would replace these and animal testing with 12-week simulations, the company said.

This is a short summary published by AI Global Wire. The full article is owned and hosted by Economic Times Tech — open it there to read it in full.

Read the full story at Economic Times Tech
  • Företag

Related AI news